Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by University of Southern California
Sponsor:
Collaborators:
AEterna Zentaris
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01240629
First received: June 30, 2010
Last updated: August 26, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)